IBDEI1LV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28493,0)
 ;;=564.00^^162^1797^41
 ;;^UTILITY(U,$J,358.3,28493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28493,1,4,0)
 ;;=4^564.00
 ;;^UTILITY(U,$J,358.3,28493,1,5,0)
 ;;=5^Constipation
 ;;^UTILITY(U,$J,358.3,28493,2)
 ;;=Constipation^323537
 ;;^UTILITY(U,$J,358.3,28494,0)
 ;;=790.22^^162^1797^88
 ;;^UTILITY(U,$J,358.3,28494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28494,1,4,0)
 ;;=4^790.22
 ;;^UTILITY(U,$J,358.3,28494,1,5,0)
 ;;=5^Impaired Oral Glucse Tol
 ;;^UTILITY(U,$J,358.3,28494,2)
 ;;=^329896
 ;;^UTILITY(U,$J,358.3,28495,0)
 ;;=719.7^^162^1797^48
 ;;^UTILITY(U,$J,358.3,28495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28495,1,4,0)
 ;;=4^719.7
 ;;^UTILITY(U,$J,358.3,28495,1,5,0)
 ;;=5^Difficulty In Walking
 ;;^UTILITY(U,$J,358.3,28495,2)
 ;;=^329945
 ;;^UTILITY(U,$J,358.3,28496,0)
 ;;=799.01^^162^1797^26
 ;;^UTILITY(U,$J,358.3,28496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28496,1,4,0)
 ;;=4^799.01
 ;;^UTILITY(U,$J,358.3,28496,1,5,0)
 ;;=5^Asphyxia
 ;;^UTILITY(U,$J,358.3,28496,2)
 ;;=^11005
 ;;^UTILITY(U,$J,358.3,28497,0)
 ;;=787.20^^162^1797^54
 ;;^UTILITY(U,$J,358.3,28497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28497,1,4,0)
 ;;=4^787.20
 ;;^UTILITY(U,$J,358.3,28497,1,5,0)
 ;;=5^Dysphagia NOS
 ;;^UTILITY(U,$J,358.3,28497,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,28498,0)
 ;;=787.21^^162^1797^55
 ;;^UTILITY(U,$J,358.3,28498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28498,1,4,0)
 ;;=4^787.21
 ;;^UTILITY(U,$J,358.3,28498,1,5,0)
 ;;=5^Dysphagia, Oral Phase
 ;;^UTILITY(U,$J,358.3,28498,2)
 ;;=^335276
 ;;^UTILITY(U,$J,358.3,28499,0)
 ;;=787.22^^162^1797^56
 ;;^UTILITY(U,$J,358.3,28499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28499,1,4,0)
 ;;=4^787.22
 ;;^UTILITY(U,$J,358.3,28499,1,5,0)
 ;;=5^Dysphagia, Oropharyngeal
 ;;^UTILITY(U,$J,358.3,28499,2)
 ;;=^335277
 ;;^UTILITY(U,$J,358.3,28500,0)
 ;;=787.23^^162^1797^57
 ;;^UTILITY(U,$J,358.3,28500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28500,1,4,0)
 ;;=4^787.23
 ;;^UTILITY(U,$J,358.3,28500,1,5,0)
 ;;=5^Dysphagia, Pharyngeal
 ;;^UTILITY(U,$J,358.3,28500,2)
 ;;=^335278
 ;;^UTILITY(U,$J,358.3,28501,0)
 ;;=787.24^^162^1797^58
 ;;^UTILITY(U,$J,358.3,28501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28501,1,4,0)
 ;;=4^787.24
 ;;^UTILITY(U,$J,358.3,28501,1,5,0)
 ;;=5^Dysphagia, Pharyngoesoph
 ;;^UTILITY(U,$J,358.3,28501,2)
 ;;=^335279
 ;;^UTILITY(U,$J,358.3,28502,0)
 ;;=787.29^^162^1797^53
 ;;^UTILITY(U,$J,358.3,28502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28502,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,28502,1,5,0)
 ;;=5^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,28502,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,28503,0)
 ;;=789.59^^162^1797^25
 ;;^UTILITY(U,$J,358.3,28503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28503,1,4,0)
 ;;=4^789.59
 ;;^UTILITY(U,$J,358.3,28503,1,5,0)
 ;;=5^Ascites NEC
 ;;^UTILITY(U,$J,358.3,28503,2)
 ;;=^335282
 ;;^UTILITY(U,$J,358.3,28504,0)
 ;;=790.29^^162^1797^84
 ;;^UTILITY(U,$J,358.3,28504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28504,1,4,0)
 ;;=4^790.29
 ;;^UTILITY(U,$J,358.3,28504,1,5,0)
 ;;=5^Hyperglycemia (Not DM)
 ;;^UTILITY(U,$J,358.3,28504,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,28505,0)
 ;;=790.6^^162^1797^10
 ;;^UTILITY(U,$J,358.3,28505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28505,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,28505,1,5,0)
 ;;=5^Abnormal Blood Chemistry
 ;;^UTILITY(U,$J,358.3,28505,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,28506,0)
 ;;=780.60^^162^1797^70
 ;;^UTILITY(U,$J,358.3,28506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28506,1,4,0)
 ;;=4^780.60
 ;;
 ;;$END ROU IBDEI1LV
